Christopher G. Hayes - Jul 5, 2022 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
VRCA
Transactions as of
Jul 5, 2022
Transactions value $
$11,999
Form type
4
Date filed
7/5/2022, 04:13 PM
Previous filing
Feb 25, 2022
Next filing
Jul 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRCA Common Stock Purchase $12K +5.71K +228.56% $2.10 8.21K Jul 5, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.